Gene Online: BIO CEO John F. Crowley on Unifying Regulation, Artificial Intelligence, and National Security into a Singular Competitiveness Agenda in Bio Sector

This sustained political advocacy culminated in the formal endorsement of the FDA’s new Project Trailblazer initiative, a milestone heavily shaped by collaborative efforts between BIO’s regulatory teams and the Reagan-Udall Foundation in Washington.